1 MIN. DE LECTURA
SANTIAGO, May 16 (Reuters) - Shares in CFR Pharmaceuticals SA jumped over 45 percent in opening trade on Friday following news that Abbott Laboratories would acquire the company in a $2.9 billion deal.
CFR shares had remained closed on the Santiago stock exchange to give the market time to digest the news. (Reporting by Santiago newsroom, Editing by Franklin Paul)